Psychoactive Substances Act 2016
The Psychoactive Substances Act 2016 is a piece of legislation enacted by the UK Parliament that aims to curb the proliferation and use of psychoactive substances, often referred to as "legal highs". Prior to the act, these substances, which mimic the effects of illegal drugs but were not covered by existing drug laws, were readily available and legal to purchase. The act received Royal Assent on 28 January 2016 and came into force on 26 May 2016.
Overview[edit]
The Psychoactive Substances Act 2016 makes it an offense to produce, supply, offer to supply, possess with intent to supply, import, or export any substance deemed to be psychoactive, with exceptions for substances like alcohol, tobacco, caffeine, food, and medical products, which are regulated under other legislation. The act defines a psychoactive substance as any substance which is capable of producing a psychoactive effect in a person who consumes it, where a psychoactive effect is described as stimulating or depressing the person’s central nervous system, affecting the person’s mental functioning or emotional state.
Key Provisions[edit]
- Blanket Ban: The act introduces a blanket ban on the production, distribution, sale, and supply of psychoactive substances in the UK.
- Exemptions: Certain substances, including alcohol, tobacco, nicotine, caffeine, and medical products, are exempt from the ban.
- Penalties: Individuals found guilty of offenses under the act can face up to 7 years in prison.
- Enforcement: The act grants powers to the police, Border Force, and other authorities to seize and destroy psychoactive substances, enter premises, and conduct searches.
Criticism and Controversy[edit]
The Psychoactive Substances Act 2016 has been subject to criticism from various quarters. Critics argue that the act's broad definition of psychoactive substances could lead to legal challenges and difficulties in enforcement. There are also concerns about the act pushing the sale of psychoactive substances into the black market, potentially increasing the risks associated with their use. Furthermore, the act has sparked a debate about the effectiveness of prohibitionist drug policies versus harm reduction approaches.
Impact[edit]
The impact of the Psychoactive Substances Act 2016 has been mixed. While there has been a reported decrease in the availability of legal highs in high street shops, evidence suggests that the use of psychoactive substances has moved to the black market. The act has also led to an increase in the confiscation of substances at UK borders.
See Also[edit]
References[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian